Dara has a broad-spectrum killing ability against CD38-expressing tumor cells through multiple mechanisms including complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, antibody-dependent cellular phagocytosis, and the induction of cell death through Fc-mediated crosslinking (5). This evidence concerns the gene CD38 and neoplasm.